Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

New infection control range for dental practices

9th Mar 2009 07:00

RNS Number : 4908O
Tristel PLC
09 March 2009
 



 

TRISTEL plc ("Tristel" or the "Company"

AIM: TSTL

New infection control range for dental practices

Tristel plc, a leading provider of infection control products into the NHS and private health sector, announces the launch of its new Dentel range, the new infection control range for dental practices.

Using the Company's unique patented chlorine dioxide chemistry, Dentel products are sporicidal and rapidly effective against all micro-organisms. Tristel's Dentel range offers NHS and private dental practices a complete infection control response to the risks encountered in all types of dental procedures. Dentel 5, Dentel 100 and Dentel Duo are sporicidal solutions and foams designed for use on dental chair water bottles, saliva ejectors, suction systems, dental chairs and instrument tables.

Tristel have appointed the Dental Buying Group, the provider of high quality products and services to the dental profession of the United Kingdom, to introduce the Dentel range into dental surgeries. The Dental Buying Group was founded to look after the buying needs of the dental practice of which there are 7,000 members who benefit from services and products aimed at saving time and money.

Tristel is already well established in the hospital setting and the launch of the new Dentel range demonstrates the potential to move into other sectors.

http://www.tristel.com/dental.html

Contacts:

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive

Daniel Stewart & Company Plc

Tel: 020 7776 6550

Graham Webster

Parkgreen Communications Ltd

Tel: 020 7933 8790

Helen Westaway

Mob: 07841 917 679

[email protected]

About Tristel

Tristel uses proprietary chlorine dioxide chemistry to create instrument and surface disinfectants. With its origins as a healthcare business specialising in infection control products, Tristel has recently extended its operations to include legionella control in water supplies and contamination control in the food and pharmaceutical industries. 

The company is creating applications for its chemistry that address the four routes of transmission of infection and contamination - surfaces, instruments, water and people.

Tristel plc has its headquarters in NewmarketUK and a network of distributors around the world. The company was admitted to trading on AIM on 1 June 2005. Its stock exchange symbol is TSTL.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAKDKESDNEFE

Related Shares:

Tristel
FTSE 100 Latest
Value8,275.66
Change0.00